Skip to main content

Change location

You are currently on the Global (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Global (English)
  • Careers
  • Media and News
  • Get in touch
    • Global (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
    • X-ray/CT
    • MRI
    • CEUS
    • Molecular Imaging
    • Cardiovascular
    • Digital Health
    • Oncology
    • Cardiology
    • Innovation
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
      • Cell Therapy
      • Research Products
        • BubbleGen CD3+ Cell Selection Kit
        • BubbleGen Cell Separators
      • Resources
    • Education
    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
    • Events
    • Key International conferences
    • Global Educational events
    • Sustainability Overview
    • Decarbonization and Environment
    • Innovation and Education
    • Empowering People
    • Trust and Governance
  • Our Stories
232 results found
Article
Stories from our 2022 Sustainability Report Conducting business in an ethical manner, supporting continuous innovation, fostering collaborative relationships with healthcare professionals, and implementing policies and actions for sustainability are all ways in which we embody our commitment.
Sustainability
Article
Bracco Imaging awarded EcoVadis Gold Medal for the second time Bracco Imaging has been reconfirmed amongst the top 5% of 100,000 global companies certified by EcoVadis for the second year in a row
Ecovadis Sustainability Rating 2024 Bracco Group
Article
EFSUMB CEUS course 2024 3rd EFSUMB CEUS course 2024 will be taking place on Nov 9/10 in parallel to the Euroson congress in Naples.
No image available
Article
Bracco Imaging and NaviFUS: a new strategic partnership Bracco Imaging announced the collaboration with NaviFUS to enhance the NaviFUS® System’s ability to open the blood-brain barrier for brain cancer and neurological disease treatments.
Bracco NaviFUS partnership
Article
Bracco Imaging and Arrayus Technologies: a new strategic partnership Bracco Imaging and Arrayus Technologies have partnered to improve drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.
Bracco Arrayus partnership
Article
AI Pills in Medical Writing This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.
AI Pills in Medical Writing
Article
Gadopiclenol receives the JFR 2024 Innovation Award Bracco Imaging is delighted to announce that Gadopiclenol (marketed as Vueway® by Bracco) has been honored with the JFR 2024 Innovation Award in the Jury's Favorite category.
Prix Innovation Award JFR 2024
Product
Vuebox: Support Fuji Non-ASR systems, currently supported for Fuji
No image available
Article
Bracco Diagnostics and Subtle Medical Announce FDA Clearance of AiMIFY™ Software Bracco Diagnostics Inc. and Subtle Medical, Inc. are thrilled to announce that their collaborative AI-powered software, AiMIFYTM, has received FDA clearance as a Class II software as a medical device (SaMD) for magnetic resonance imaging (MRI) of the brain.
BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.
Article
Hexagon: A new era begins With the inauguration of Hexagon, Bracco unveils its new cutting-edge manufacturing facility in Plan-les-Ouates, Geneva, Switzerland, making a significant milestone in the company's long history of innovation.
Bracco production innovative ultrasound contrast agent Geneva
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Education
  • Events
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182